Cilta-cel

ciltacabtagene autoleucel · Legend Biotech; Janssen Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cilta-cel, covering 2026-02-13 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma

See pricing